SCHEMBL3787922

SCHEMBL3787922

NCc1ccc(-c2cccc(N)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 5/20 0.64
MAOA P21397 1/20 0.64
CYP3A4 P08684 2/20 0.62
CYP19A1 P11511 2/20 0.62
CYP17A1 P05093 1/20 0.62
CYP11B1 P15538 1/20 0.62
CYP11B2 P19099 1/20 0.62
HRH3 Q9Y5N1 1/20 0.61
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
LOXL2 Q9Y4K0 1/20 0.52
MAP4K4 O95819 2/20 0.50
CYP2A6 P11509 1/20 0.50
MAOB P27338 2/20 0.47
MEN1 O00255 1/20 0.47
PSIP1 O75475 1/20 0.47
AXL P30530 1/20 0.47
MKNK1 Q9BUB5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31716352 0.98 TAAR1 (0.61) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL2134718 0.96 MAOA (0.62) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL3790473 0.87 MAOA (0.58) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL17350172 0.87 CYP3A4 (0.79) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL30661714 0.87 MAOA (0.58) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL29394565 0.86 MAOA (0.84) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL29561461 0.86 MAOA (0.84) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL31131353 0.86 MAOA (0.84) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL311194 0.86 MAOA (0.84) TAAR1MAOACYP3A4CYP19A1CYP17A1
SCHEMBL19446666 0.86 MAOA (0.84) TAAR1MAOACYP3A4CYP19A1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
WO-2009006315-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS FOR TREATING CYSTIC FIBROSIS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-01-08 WO disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 TAAR1 1746/4885MAOA 348/4885CYP3A4 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.